Search Results 21-30 of 16441 for Huntington's+disease
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...
Understand more about this brain disorder that's the most common cause of dementia. Also learn about new tests and medicines on the market.
Publications. Mu L, Chen J, Nyirenda T, Li J, Hegland KW, Adler CH, Caviness JN, Shill HA, Serrano GE, Beach TG, Arizona Parkinson's Disease Consortium.
Creutzfeldt-Jakob (KROITS-felt YAH-kobe) disease, also known as CJD, is a rare brain disorder that leads to dementia. It belongs to a group of human and ...
It is driven by a single genetic variant that causes an abnormal buildup of a protein. This disrupts nerve cell function and the brain's signaling network. Over ...
... and/or bad of two treatment methods on subjects and their cancer. ... disease and factors that may determine disease progression and treatment response. ... AMP-514 ...
Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition. Brain Tumor Program ...
Ertekin-Taner's laboratory within the umbrella of the Accelerating Medicines Partnership — Alzheimer's Disease (AMP-AD) consortium. In this project ...
Research. Mayo Clinic researchers develop new treatments for adults with congenital heart diseases and study the genetic causes of some of those diseases. Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.